Trials / Completed
CompletedNCT02710955
SWAN: Study on the Tolerance and Efficacy of a New Anti-regurgitation Formula (PC-2016-01)
Study on the Tolerance and Efficacy of a New Anti-regurgitation Formula (PC-2016-01)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- United Pharmaceuticals · Industry
- Sex
- All
- Age
- 1 Week – 5 Months
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the efficacy of a new thickened formula on regurgitation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Thickened infant formula |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2017-01-21
- Completion
- 2017-04-12
- First posted
- 2016-03-17
- Last updated
- 2017-11-14
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02710955. Inclusion in this directory is not an endorsement.